calsequestrin 2 Inhibitors

The chemical class of Calsequestrin 2 inhibitors includes a range of compounds that indirectly influence the function of CASQ2 by modulating calcium dynamics in cardiac muscle cells. These compounds primarily target calcium channels, ryanodine receptors, and other components of the calcium signaling pathway, which are closely linked to the function of CASQ2 in calcium storage and regulation. Calcium channel blockers like Nifedipine, Verapamil, Amlodipine, and their counterparts selectively inhibit the influx of calcium ions through the L-type calcium channels in the cardiac muscle cell membrane. By reducing calcium influx, these compounds indirectly impact the calcium load and, consequently, the buffering capacity of CASQ2 in the sarcoplasmic reticulum. This modulation of calcium homeostasis is crucial in cardiac physiology, particularly in the context of controlling cardiac muscle contraction and relaxation.

On the other hand, compounds like Ryanodine, Dantrolene, and Caffeine interact with the ryanodine receptors (RyRs) on the sarcoplasmic reticulum. These receptors are integral to the release of calcium ions during muscle contraction. By modulating the activity of RyRs, these compounds indirectly influence the release of calcium and thus the role of CASQ2 in calcium sequestration and release during the cardiac cycle. Thapsigargin represents another approach by inhibiting the SERCA (Sarco/Endoplasmic Reticulum Ca2+-ATPase) pump, which is responsible for pumping calcium back into the sarcoplasmic reticulum, thereby affecting the calcium storage capacity and indirectly the function of CASQ2.